Sanofi (SNY)
43.33
+0.56
(+1.31%)
USD |
NASDAQ |
Sep 14, 16:00
43.33
0.00 (0.00%)
After-Hours: 20:00
Sanofi Price to Book Value : 1.460 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 1.460 |
| September 11, 2026 | 1.441 |
| September 10, 2026 | 1.439 |
| September 09, 2026 | 1.444 |
| September 08, 2026 | 1.454 |
| September 04, 2026 | 1.490 |
| September 03, 2026 | 1.493 |
| September 02, 2026 | 1.498 |
| September 01, 2026 | 1.495 |
| August 31, 2026 | 1.494 |
| August 28, 2026 | 1.510 |
| August 27, 2026 | 1.510 |
| August 26, 2026 | 1.530 |
| August 25, 2026 | 1.550 |
| August 24, 2026 | 1.539 |
| August 21, 2026 | 1.545 |
| August 20, 2026 | 1.521 |
| August 19, 2026 | 1.544 |
| August 18, 2026 | 1.515 |
| August 17, 2026 | 1.496 |
| August 14, 2026 | 1.473 |
| August 13, 2026 | 1.475 |
| August 12, 2026 | 1.472 |
| August 11, 2026 | 1.467 |
| August 10, 2026 | 1.465 |
| Date | Value |
|---|---|
| August 07, 2026 | 1.464 |
| August 06, 2026 | 1.445 |
| August 05, 2026 | 1.441 |
| August 04, 2026 | 1.438 |
| August 03, 2026 | 1.447 |
| July 31, 2026 | 1.451 |
| July 30, 2026 | 1.445 |
| July 29, 2026 | 1.511 |
| July 28, 2026 | 1.534 |
| July 27, 2026 | 1.482 |
| July 24, 2026 | 1.460 |
| July 23, 2026 | 1.461 |
| July 22, 2026 | 1.475 |
| July 21, 2026 | 1.474 |
| July 20, 2026 | 1.482 |
| July 17, 2026 | 1.504 |
| July 16, 2026 | 1.489 |
| July 15, 2026 | 1.472 |
| July 14, 2026 | 1.455 |
| July 13, 2026 | 1.482 |
| July 10, 2026 | 1.465 |
| July 09, 2026 | 1.479 |
| July 08, 2026 | 1.441 |
| July 07, 2026 | 1.448 |
| July 06, 2026 | 1.435 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 10.73 |
| GSK Plc | 4.323 |
| Eli Lilly & Co. | 31.63 |
| Merck & Co., Inc. | 8.528 |
| Novo Nordisk A/S | 5.675 |
Price to Book Value Related Metrics
| PE Ratio | 22.32 |
| PS Ratio | 1.958 |
| PEG Ratio | 3.170 |
| Price to Free Cash Flow | 10.59 |
| Price | 43.33 |
| Earnings Yield | 4.48% |
| Market Cap | 105.21B |
| PEGY Ratio | 1.767 |
| Operating PE Ratio | 7.207 |
| Normalized PE Ratio | 12.61 |